Trial Profile
Levosimendan in Congenital Cardiac Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Milrinone
- Indications Low cardiac output
- Focus Therapeutic Use
- 27 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2008 Status changed from not yet recruiting to recruiting.
- 09 Jul 2008 New trial record.